Harnessing SLE autoantibodies for intracellular delivery of biologic therapeutics

RE Gordon, JF Nemeth, S Singh, RB Lingham… - Trends in …, 2021 - cell.com
Intracellular delivery of therapeutic antibodies is highly desirable but remains a challenge for
biomedical research and the pharmaceutical industry. Approximately two-thirds of disease …
被引用次数：24 相关文章

Harnessing SLE Autoantibodies for Intracellular Delivery of Biologic Therapeutics

RE Gordon, JF Nemeth, S Singh… - Trends in …, 2021 - pubmed.ncbi.nlm.nih.gov
Intracellular delivery of therapeutic antibodies is highly desirable but remains a challenge for
biomedical research and the pharmaceutical industry. Approximately two-thirds of disease …

Harnessing SLE Autoantibodies for Intracellular Delivery of Biologic Therapeutics.

RE Gordon, JF Nemeth, S Singh… - Trends in …, 2020 - europepmc.org
Intracellular delivery of therapeutic antibodies is highly desirable but remains a challenge for
biomedical research and the pharmaceutical industry. Approximately two-thirds of disease …

Harnessing SLE Autoantibodies for Intracellular Delivery of Biologic Therapeutics

RE Gordon, JF Nemeth, S Singh, RB Lingham… - Trends in …, 2021 - Elsevier
HighlightsAntibodies were thought to be unable to penetrate inside the cytosol and
intracellular compartments. This concept was challenged by the discovery of naturally …

[引用][C] Harnessing SLE Autoantibodies for Intracellular Delivery of Biologic Therapeutics

RE Gordon, JF Nemeth, S Singh, RB Lingham… - 2021